Substituted diazepan orexin receptor antagonists

Details for Australian Patent Application No. 2008319419 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Bergman, Jeffrey M.; Coleman, Paul J.; Cox, Christopher D.; Roecker, Anthony J.

Agent Spruson & Ferguson

Pub. Number AU-A-2008319419

PCT Pub. Number WO2009/058238

Priority 61/000,760 29.10.07 US

Filing date 27 October 2008

Wipo publication date 7 May 2009

International Classifications

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 243/06 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/058238 Priority application(s): WO2009/058238

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008319421-Gaming system having graphical user interface for configuration of wagering games

2008319418-Antidiabetic tricyclic compounds